These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 9360675

  • 1. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA.
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [Abstract] [Full Text] [Related]

  • 2. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 3. Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?
    Nauck M, Krämer-Guth A, Bartens W, März W, Wieland H, Wanner C.
    Clin Nephrol; 1996 Nov; 46(5):319-25. PubMed ID: 8953121
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D, Szprynger K.
    Przegl Lek; 1997 Apr; 54(5):320-3. PubMed ID: 9380806
    [Abstract] [Full Text] [Related]

  • 8. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.
    J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein (a) levels and clinical correlations in CAPD patients.
    Lye WC, Hughes K, Leong SO, Lee EJ.
    Adv Perit Dial; 1995 Jul; 11():131-3. PubMed ID: 8534686
    [Abstract] [Full Text] [Related]

  • 10. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X, Sentí M, Pedro-Botet J, Molina L, Serrat R, Pons S, Rubiés-Prat J.
    Med Clin (Barc); 1992 Feb 08; 98(5):171-4. PubMed ID: 1532436
    [Abstract] [Full Text] [Related]

  • 11. Effect of beta-blocker therapy on serum lipoprotein profiles in patients on renal dialysis and in diabetic nephropathy.
    Kontessis PS, Jayathissa SA, Walker JD, Mattock MB, Williams DG, Viberti GC.
    Diabetes Res; 1993 Feb 08; 23(3):93-104. PubMed ID: 7712687
    [Abstract] [Full Text] [Related]

  • 12. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
    Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H.
    Clin Nephrol; 1992 Nov 08; 38(5):271-6. PubMed ID: 1451340
    [Abstract] [Full Text] [Related]

  • 13. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
    Jakić M, Lovcić V, Klarić D, Mihaljević D, Zibar L, Jakić M, Marić I.
    Coll Antropol; 2010 Mar 08; 34 Suppl 1():181-8. PubMed ID: 20402316
    [Abstract] [Full Text] [Related]

  • 14. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S.
    Nihon Jinzo Gakkai Shi; 1994 Jun 08; 36(6):746-51. PubMed ID: 8084076
    [Abstract] [Full Text] [Related]

  • 15. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
    Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG.
    Perit Dial Int; 1995 Jun 08; 15(8):342-7. PubMed ID: 8785232
    [Abstract] [Full Text] [Related]

  • 16. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May 08; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 17. Changes in lipid profiles in non diabetic, non nephrotic patients commencing continuous ambulatory peritoneal dialysis.
    O'Riordan E, O'Donoghue DJ, Kalra PA, Foley RN, Waldek S.
    Adv Perit Dial; 2000 May 08; 16():313-6. PubMed ID: 11045318
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC.
    Am J Kidney Dis; 1999 Jun 08; 33(6):1100-6. PubMed ID: 10352198
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 08; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 20. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
    Kim CJ, Ryu WS, Kwak JW, Park CT, Ryoo UH.
    Arch Intern Med; 1996 Mar 11; 156(5):500-4. PubMed ID: 8604955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.